Comparing the Antithrombotic Efficacy of a Humanized Anti-factor IX(a) Monoclonal Antibody (SB 249417) to the Low Molecular Weight Heparin Enoxaparin In a Rat Model of Arterial Thrombosis
- 1 October 2000
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 100 (1) , 73-79
- https://doi.org/10.1016/s0049-3848(00)00299-1
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Low-Molecular-Weight HeparinCirculation, 1998
- Low-Molecular-Weight HeparinsNew England Journal of Medicine, 1997
- A Comparison of Low-Molecular-Weight Heparin with Unfractionated Heparin for Acute Pulmonary EmbolismNew England Journal of Medicine, 1997
- A Comparison of Low-Molecular-Weight Heparin with Unfractionated Heparin for Unstable Coronary Artery DiseaseNew England Journal of Medicine, 1997
- Aspirin, Heparin, and Fibrinolytic Therapy in Suspected Acute Myocardial InfarctionNew England Journal of Medicine, 1997
- Adding heparin to aspirin reduces the incidence of myocardial infarction and death in patients with unstable angina. A meta-analysisJAMA, 1996
- Reactivation of Unstable Angina after the Discontinuation of HeparinNew England Journal of Medicine, 1992
- ISIS-3: a randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41 299 cases of suspected acute myocardial infarctionPublished by Elsevier ,1992
- Risk of myocardial infarction and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary artery diseaseThe Lancet, 1990
- RANDOMISED TRIAL OF INTRAVENOUS STREPTOKINASE, ORAL ASPIRIN, BOTH, OR NEITHER AMONG 17 187 CASES OF SUSPECTED ACUTE MYOCARDIAL INFARCTION: ISIS-2Published by Elsevier ,1988